Company Filing History:
Years Active: 2023
Title: Frank Weiss: Innovator in Coronavirus Treatment
Introduction
Frank Weiss is a notable inventor based in La Jolla, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of treatments for viral infections.
Latest Patents
Frank Weiss holds a patent for "Protease inhibitors for treatment of coronavirus infections." This patent includes compounds of Formula (I), their pharmaceutically acceptable salts, and their pharmaceutical compositions. The compounds are identified as potent inhibitors of the main protease (M) of severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2). They are useful in treating or preventing COVID-19 in a subject.
Career Highlights
Frank Weiss is affiliated with The Scripps Research Institute, where he conducts his research and development work. His innovative approach to drug design has positioned him as a key figure in the fight against viral diseases.
Collaborations
Some of his notable coworkers include Arnab Kumar Chatterjee and Jian Jeffrey Chen. Their collaborative efforts contribute to advancing research in the field of virology.
Conclusion
Frank Weiss is a dedicated inventor whose work in developing protease inhibitors plays a crucial role in addressing coronavirus infections. His contributions are vital in the ongoing battle against COVID-19.